By Australia worry-free network (https://australia51.com) collection, collation and translation from a number of English media, welcome to reprint, but please keep the source and original URL, thank you.
One official of the World Health Organization (WHO) said that before the vaccine was widely used, the number of global death caused by Coronavirus could double to 2 million, and that the number could be higher if countries around the world failed to take concerted action to contain the pandemic.
"Unless we go all out (2 million death) is not only conceivable, but very likely. "Common Country Agency Emergency Project Manager Mike Ryan (Mike Ryan) said at a briefing Friday.
WHO are continuing negotiations with China to discuss the possibility of its involvement in a COVAX financing plan aimed at ensuring rapid and equitable access to Coronavirus vaccine. worldwide
WHO senior consultant, Canadian epidemiologist Bruce Elward (Bruce Aylward) said :& quot; we are discussing with China their possible role. & quot;.
Bruce Elwald
bruce confirmed that although TW is not a WHO member, the program has been signed, bringing the total number of participants to 159. Some 34 countries are still deciding whether to join.
WHO Director-General Tedros said that the world must prepare for the next pandemic, and he called on countries to increase investment in public health.
According to an earlier report by the The British Broadcasting Corporation , there are currently three vaccines in China undergoing phase III clinical trials, one of which is an attenuated vaccine jointly developed by the Chinese military and Kangsino The last of the inactivated vaccines jointly developed by the Institute of Virus Control is the inactivated vaccine jointly developed by the Chinese Academy of Medical Sciences and Kexing Zhongwei Bio. The U.S. government is also stepping up vaccine research and development, and at the same time launching a vaccine procurement plan around the world, with a view to providing people with free vaccination as soon as possible.
The Australian Federal government signed a vaccine purchase agreement with Oxford University and AstraZeneca (AstraZeneca) in early September. If the candidate new crown vaccine successfully passed the clinical trial, it would be ordered on a large scale and would be produced in Australia.
